Suppr超能文献

用于癌症生物标志物发现的小鼠模型库。

A mouse model repository for cancer biomarker discovery.

作者信息

Kelly-Spratt Karen S, Kasarda A Erik, Igra Mark, Kemp Christopher J

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

出版信息

J Proteome Res. 2008 Aug;7(8):3613-8. doi: 10.1021/pr800210b. Epub 2008 Jul 15.

Abstract

Early detection of cancer using biomarkers obtained from blood or other easily accessible tissues would have a significant impact on reducing cancer mortality. However, identifying new blood-based biomarkers has been hindered by the dynamic complexity of the human plasma proteome, confounded by genetic and environmental variability, and the scarcity of high quality controlled samples. In this report, we discuss a new paradigm for biomarker discovery through the use of mouse models. Inbred mouse models of cancer recapitulate many critical features of human cancer, while eliminating sources of environmental and genetic variability. The ability to collect samples from highly matched cases and controls under identical conditions further reduces variability which is critical for successful biomarker discovery. We describe the establishment of a repository containing tumor, plasma, urine, and other tissues from 10 different mouse models of human cancer, including two breast, two lung, two prostate, two gastrointestinal, one ovarian, and one skin tumor model. We present the overall design of this resource and its potential use by the research community for biomarker discovery.

摘要

利用从血液或其他易于获取的组织中获得的生物标志物进行癌症的早期检测,将对降低癌症死亡率产生重大影响。然而,人类血浆蛋白质组的动态复杂性、遗传和环境变异性的干扰以及高质量对照样本的稀缺,阻碍了新型血液生物标志物的识别。在本报告中,我们讨论了一种通过使用小鼠模型发现生物标志物的新范式。癌症近交系小鼠模型概括了人类癌症的许多关键特征,同时消除了环境和遗传变异性的来源。在相同条件下从高度匹配的病例和对照中收集样本的能力进一步降低了变异性,这对于成功发现生物标志物至关重要。我们描述了一个储存库的建立,该储存库包含来自10种不同人类癌症小鼠模型的肿瘤、血浆、尿液和其他组织,包括两种乳腺癌、两种肺癌、两种前列腺癌、两种胃肠道癌、一种卵巢癌和一种皮肤肿瘤模型。我们展示了该资源的总体设计及其在生物标志物发现方面可供研究界使用的潜力。

相似文献

1
A mouse model repository for cancer biomarker discovery.用于癌症生物标志物发现的小鼠模型库。
J Proteome Res. 2008 Aug;7(8):3613-8. doi: 10.1021/pr800210b. Epub 2008 Jul 15.
2
Streamlining biomarker discovery.简化生物标志物发现流程。
Nat Biotechnol. 2011 Jul 11;29(7):600-2. doi: 10.1038/nbt.1917.
3
Systematic, evidence-based discovery of biomarkers at the NCI.在 NCI 进行系统的、基于证据的生物标志物发现。
Clin Exp Metastasis. 2012 Oct;29(7):645-52. doi: 10.1007/s10585-012-9507-z. Epub 2012 Aug 7.
4
Exploration of the platelet proteome in patients with early-stage cancer.早期癌症患者血小板蛋白质组的探索。
J Proteomics. 2018 Apr 15;177:65-74. doi: 10.1016/j.jprot.2018.02.011. Epub 2018 Feb 10.
8
Urinary biomarkers in prostate cancer detection and monitoring progression.用于前列腺癌检测和监测病情进展的尿液生物标志物。
Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19.

引用本文的文献

本文引用的文献

5
Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.Exo1和Fen1缺陷的Apc(1638N)小鼠中的肿瘤进展
Oncogene. 2007 Sep 20;26(43):6297-306. doi: 10.1038/sj.onc.1210453. Epub 2007 Apr 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验